Propranolol hydrochloride

Pricing Availability   Qty
Description: β antagonist
Chemical Name: (RS)-1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol hydrochloride
Datasheet
Citations (13)
Reviews (1)
Literature (1)

Biological Activity for Propranolol hydrochloride

Propranolol hydrochloride is an β-adrenergic antagonist.

R-enantiomer, S-enantiomer and Glycol Metabolite also available.

Scientific Data

Binding Activity View Larger

Small molecules affect the rate of cardiomyocyte contraction. Cardiomyocytes were differentiated from the BG01V human embryonic stem cells and assessed for their ability to contract using the Fluo-4 calcium binding assay. Rate interval graph show fluctuations in Fluo-4 fluorescence intensity, indicative of cardiomyocyte contraction, under basal conditions (brown; untreated) and following sequential treatment with Isoproterenol (blue; Catalog # 1747), a beta -adrenergic agonist, and Propranolol (tan; Catalog # 0624), a beta -adrenergic antagonist. Table shows drug concentrations and contraction rate of cardiomyocytes during each treatment. The contraction rate of differentiated cardiomyocytes was determined as the number of contractions (contraction-interval plus relaxation interval) per minute.

Technical Data for Propranolol hydrochloride

M. Wt 295.81
Formula C16H21NO2.HCl
Storage Store at RT
CAS Number 318-98-9
PubChem ID 62882
InChI Key ZMRUPTIKESYGQW-UHFFFAOYSA-N
Smiles Cl.CC(C)NCC(O)COC1=C2C=CC=CC2=CC=C1

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

Solubility Data for Propranolol hydrochloride

Solvent Max Conc. mg/mL Max Conc. mM
Solubility
water 29.58 100

Preparing Stock Solutions for Propranolol hydrochloride

The following data is based on the product molecular weight 295.81. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Select a batch to recalculate based on the batch molecular weight:
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 3.38 mL 16.9 mL 33.81 mL
5 mM 0.68 mL 3.38 mL 6.76 mL
10 mM 0.34 mL 1.69 mL 3.38 mL
50 mM 0.07 mL 0.34 mL 0.68 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

Product Datasheets for Propranolol hydrochloride

References for Propranolol hydrochloride

References are publications that support the biological activity of the product.

Litwin et al (1999) Effects of propra. treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. Br.J.Pharmacol. 127 1671 PMID: 10455325

Xie et al (1998) The inhibitory effect of propra. on ATP-sensitive potassium channels in neonatal rat heart. Br.J.Pharmacol. 123 599 PMID: 9517376

Merck Index 12 8025


If you know of a relevant reference for Propranolol hydrochloride, please let us know.

View Related Products by Product Action

View all Non-selective Adrenergic β Receptor Antagonists

Keywords: Propranolol hydrochloride, Propranolol hydrochloride supplier, β-adrenoceptor, beta-adrenoceptors, b-adrenoceptors, b-adrenergic, antagonists, β-adrenergic, beta-adrenergic, Receptors, Non-Selective, β-blockers, beta-blockers, 3506-09-0, Non-selective, Adrenergic, Beta, 0624, Tocris Bioscience

13 Citations for Propranolol hydrochloride

Citations are publications that use Tocris products. Selected citations for Propranolol hydrochloride include:

Shi et al (2010) Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Purinergic Signal 9 269 PMID: 20939893

Bucher et al (2014) Medullary NE neurons modulate local oxygen concentrations in the bed nucleus of the stria terminalis. J Cereb Blood Flow Metab 34 1128 PMID: 24714037

Gherbi et al (2014) Detection of the secondary, low-affinity β1 -adrenoceptor site in living cells using the fluorescent CGP 12177 derivative BODIPY-TMR-CGP. Br J Pharmacol 171 5431 PMID: 25052258

McKeithan et al (2017) An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes. Front Physiol 8 766 PMID: 29075196


Do you know of a great paper that uses Propranolol hydrochloride from Tocris? Please let us know.

Reviews for Propranolol hydrochloride

Average Rating: 5 (Based on 1 Review.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Propranolol hydrochloride?

Submit a review and receive an Amazon gift card.

$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Propranolol hydrochroride treated postnatal mice decreased PI3K activity in heart.
By YANCHUN XU on 01/05/2018
Assay Type: In Vivo
Species: Mouse
Cell Line/Tissue: heart

We used Propranolol hydrochroride (cat#0624) to treat postnatal mice to investigate the PI3K activity change

review image

Literature in this Area

Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!

*Please note that Tocris will only send literature to established scientific business / institute addresses.


Depression Poster

Depression Poster

Major depressive disorder is characterized by depressed mood and a loss of interest and/or pleasure. Updated in 2015 this poster highlights presynaptic and postsynaptic targets for the potential treatment of major depressive disorder, as well as outlining the pharmacology of currently approved antidepressant drugs.